145 related articles for article (PubMed ID: 1602643)
21. Tomographic myocardial perfusion imaging with technetium-99m-teboroxime at rest and after dipyridamole.
Li QS; Solot G; Frank TL; Wagner HN; Becker LC
J Nucl Med; 1991 Oct; 32(10):1968-76. PubMed ID: 1919740
[TBL] [Abstract][Full Text] [Related]
22. Detecting coronary artery disease using SPECT imaging: a comparison of thallium-201 and teboroxime.
Fleming RM
Am J Physiol Imaging; 1992; 7(1):20-3. PubMed ID: 1520504
[TBL] [Abstract][Full Text] [Related]
23. Experimental verification of technetium 99m-labeled teboroxime kinetic parameters in the myocardium with dynamic single-photon emission computed tomography: reproducibility, correlation to flow, and susceptibility to extravascular contamination.
Smith AM; Gullberg GT; Christian PE
J Nucl Cardiol; 1996; 3(2):130-42. PubMed ID: 8799238
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic value of a new myocardial perfusion agent, 99mTc-teboroxime (SQ30,217) in patients with coronary artery disease, utilizing a SPECT imaging protocol: a multicenter phase III clinical trial].
Kozuka T; Ishida Y; Kubo A; Otake T; Sasaki Y; Fujimori K; Furudate M; Kobayashi T; Takahashi T; Yanagisawa T
Kaku Igaku; 1992 Dec; 29(12):1399-417. PubMed ID: 1491486
[TBL] [Abstract][Full Text] [Related]
25. [Myocardial scintigraphy with Tc-99m-teboroxime: its feasibility and the evaluation of its diagnostic reliability. A comparison with thallium-201 and coronary angiography].
Bisi G; Sciagrà R; Santoro GM; Cerisano G; Vella A; Zerauschek F; Fazzini PF
G Ital Cardiol; 1992 Jul; 22(7):795-805. PubMed ID: 1473653
[TBL] [Abstract][Full Text] [Related]
26. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
Weinstein H; Reinhardt CP; Leppo JA
J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m teboroxime scintigraphy. Clinical experience in patients referred for myocardial perfusion evaluation.
Bontemps L; Geronicola-Trapali X; Sayegh Y; Delmas O; Itti R; André-Fouët X
Eur J Nucl Med; 1991; 18(9):732-9. PubMed ID: 1936049
[TBL] [Abstract][Full Text] [Related]
28. Preliminary report of SPECT imaging with Tc-99m teboroxime in ischemic heart disease.
Drane WE; Keim S; Strickland P; Tineo A; Nicole M
Clin Nucl Med; 1992 Mar; 17(3):215-25. PubMed ID: 1611794
[TBL] [Abstract][Full Text] [Related]
29. Myocardial perfusion imaging using single-photon emission computed tomography.
Garvin AA; Cullom SJ; Garcia EV
Am J Card Imaging; 1994 Apr; 8(2):189-98. PubMed ID: 8032191
[TBL] [Abstract][Full Text] [Related]
30. Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging.
Fleming RM; Kirkeeide RL; Taegtmeyer H; Adyanthaya A; Cassidy DB; Goldstein RA
J Am Coll Cardiol; 1991 May; 17(6):1297-302. PubMed ID: 2016447
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience with technetium 99m teboroxime.
Johnson LL
Semin Nucl Med; 1991 Jul; 21(3):182-9. PubMed ID: 1948111
[TBL] [Abstract][Full Text] [Related]
32. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin.
Nakajima K; Taki J; Shuke N; Bunko H; Takata S; Hisada K
J Nucl Med; 1993 Sep; 34(9):1478-84. PubMed ID: 8355067
[TBL] [Abstract][Full Text] [Related]
33. Myocardial accumulation and clearance of technetium 99m teboroxime at 100%, 75%, 50% and zero coronary blood flow in dogs.
Pieri P; Yasuda T; Fischman AJ; Ahmad M; Moore R; Yaoita H; Strauss HW
Eur J Nucl Med; 1991; 18(9):725-31. PubMed ID: 1936048
[TBL] [Abstract][Full Text] [Related]
34. Clinical utility of technetium-99m-teboroxime myocardial washout imaging.
Henzlova MJ; Machac J
J Nucl Med; 1994 Apr; 35(4):575-9. PubMed ID: 8151378
[TBL] [Abstract][Full Text] [Related]
35. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
Johnson LL; Seldin DW
Am J Cardiol; 1990 Oct; 66(13):63E-67E. PubMed ID: 2220625
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m teboroxime regional myocardial washout in subjects with and without coronary artery disease.
Chua T; Kiat H; Germano G; Palmas W; Takemoto K; Friedman J; Berman DS
Am J Cardiol; 1993 Sep; 72(9):728-34. PubMed ID: 8249853
[TBL] [Abstract][Full Text] [Related]
37. Comparison between technetium-99m-teboroxime and thallium-201 dipyridamole planar myocardial perfusion imaging in detection of coronary artery disease.
Labonté C; Taillefer R; Lambert R; Basile F; TonThat T; Jarry M; Léveillé J
Am J Cardiol; 1992 Jan; 69(1):90-6. PubMed ID: 1729873
[TBL] [Abstract][Full Text] [Related]
38. Kinetic modeling of teboroxime using dynamic SPECT imaging of a canine model.
Smith AM; Gullberg GT; Christian PE; Datz FL
J Nucl Med; 1994 Mar; 35(3):484-95. PubMed ID: 8113904
[TBL] [Abstract][Full Text] [Related]
39. Myocardial perfusion imaging with technetium-99m-teboroxime.
Johnson LL
J Nucl Med; 1994 Apr; 35(4):689-92. PubMed ID: 8151395
[TBL] [Abstract][Full Text] [Related]
40. Myocardial perfusion imaging with technetium-99m-labeled agents.
Maddahi J; Kiat H; Berman DS
Am J Cardiol; 1991 May; 67(14):27D-34D. PubMed ID: 1827941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
